在心脏参与的全身性硬化症中血清标志物
1Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Kocaeli University, İzmit, Kocaeli, Turkey. drngokcen@hotmail.com.
Clinical rheumatology
|June 19, 2023
概括
血清生物标志物在早期检测系统性硬化症 (SSc) 中心脏参与方面表现有前途. 这篇评论强调了它们在诊断初级SSc心脏参与 (SSc-pHI) 和预测预后方面的潜力.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 心脏参与是系统性硬化症 (SSc) 的常见并发症,从无症状到严重的疾病.
- 主要SSc心脏参与 (SSc-pHI) 被定义为由SSc直接引起的心脏问题,与其他心脏病不同.
- 早期识别SSc中的心脏参与对于患者管理和结果至关重要.
研究的目的:
- 审查血清生物标志物的实用性,以诊断系统性硬化症中的心脏参与.
- 确定有前途的生物标志物用于早期检测初级SSc心脏参与 (SSc-pHI).
- 评估血清生物标志物在预测心脏病患者SSc患者疾病预后方面的作用.
主要方法:
- 这篇叙述性综述系统地搜索和分析了关于血清生物标志物的现有文献,以确定系统性硬化症中的心脏参与.
- 审查的重点是评估各种血清生物标志物的诊断准确性和预后价值的研究.
- 重点放在与初级SSc心脏参与 (SSc-pHI) 相关的生物标志物上.
主要成果:
- 几种血清生物标志物已经显示出在SSc患者中识别心脏参与的潜力,即使没有明显的症状.
- 生物标志物可能有助于区分初级SSc心脏参与 (SSc-pHI) 和其他心脏疾病.
- 目前正在研究某些生物标志物对疾病进展和预后的预测价值.
结论:
- 血清生物标志物是一种非侵入性和有效的工具,用于查和诊断系统性硬化症中心脏参与.
- 需要进一步的研究来验证这些生物标志物在早期SSc-pHI检测和预后中常规临床使用.
- 将血清生物标志物纳入临床实践可以显著改善心脏并发症的SSc患者的管理.
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
204
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204
01:23Rheumatic Heart Disease I: Introduction
17
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:27Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12